Table 1.
Rotavirus genotypes identified in stool sample collected for cases of acute gastroenteritis.
| Genotype | No. (%) | No. per schedule |
Vesikari score |
|||
|---|---|---|---|---|---|---|
| Neonatal | Infant | Placebo | Not severe (<11) | Severe (≥11) | ||
| G3P[8] | 90 (85.7%) | 20 | 23 | 47 | 38 | 52 |
| G2P[6] | 5 (4.7%) | 0 | 3 | 2 | 5 | 0 |
| G3P[6] | 1 (<1%) | 0 | 0 | 1 | 0 | 1 |
| G1P[8] | 1 (<1%) | 1 | 0 | 0 | 1 | 0 |
| Mixed (G2,3P[6]) | 1 (<1%) | 1 | 0 | 0 | 1 | 0 |
| Partial Type (GXP[8]; G3P[X]) | 7 (6.6%) | 1 | 3 | 3 | 4 | 3 |
| Total | 105 | 23 | 29 | 53 | 49 | 56 |
Neonate and Infant schedule participants received RV3-BB vaccine according the dosing schedule described in Section 2. Severe gastroenteritis defined by a Vesikari score ≥11.